Status:

RECRUITING

Feasibility Test of Action Planning in Pediatric IBD

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborating Sponsors:

National Center for Advancing Translational Sciences (NCATS)

Conditions:

Inflammatory Bowel Diseases

Eligibility:

All Genders

13-19 years

Phase:

NA

Brief Summary

The goal of this interventional study is to test the feasibility of a new communication tool, call MyIBD, in youth ages 13 to 19 years with inflammatory bowel disease. The main question\[s\] it aims t...

Detailed Description

Quality of care for youth with chronic disease suffers because of gaps in care coordination and communication among patients/families and multiple health care providers. As youth with inflammatory bow...

Eligibility Criteria

Inclusion

  • age 13-19 years old at time of recruitment; AND
  • diagnosis at least 3 months earlier of Crohn's disease, ulcerative colitis, or indeterminate colitis (to exclude families who have not had sufficient time to become familiar with condition and/or clinic personnel); AND
  • receiving ongoing care at UNC (at least one visit in the past year)

Exclusion

  • speaker of a language other than English or Spanish

Key Trial Info

Start Date :

February 5 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06186752

Start Date

February 5 2024

End Date

March 1 2026

Last Update

May 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of North Carolina-Chapel Hill School of Medicine

Chapel Hill, North Carolina, United States, 27599